Deloitte said Monday Anderson will oversee the firm’s health outcome improvement efforts through the advancement of platforms and collaboration with stakeholders across federal health, life sciences and nonprofit sectors.
Anderson’s “time at FasterCures, as well as her close work with other major health organizations, such as the National Institutes of Health and the Food and Drug Administration, offers valuable experience to support our clients and our efforts to drive improved patient care and outcomes,” said Kevin Brault, principal at Deloitte & Touche and federal health sector leader.
Anderson spent more than a decade at FasterCures, a Milken Institute-run center that seeks to facilitate collaboration across sectors and integrate patients into the research process.
Before FasterCures, she served as deputy director and a team leader at the Academy for Educational Development’s Center on AIDS & Community Health.
Anderson also worked at the American Public Health Association as a health science analyst and program director at the Society for Women’s Health Research.
She sits on the boards of the Melanoma Research Alliance, NIH’s Advancing Cures Today and the Asthma and Allergy Foundation and is a founding member of NIH’s National Center for Advancing Translational Sciences Advisory Council and past-president of the Alliance for a Stronger FDA.